Omeros Corp (OMER): Capital Expenditures
$65.0K
Year ended 2025-12-31
$56.0K
Trailing 12 months to 2026-06-30
-16.8%
3-year compound annual growth
-25.5%
5-year compound annual growth
-12.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $65.0K | -60.6% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $165.0K | -61.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $426.0K | +277.0% | 2026-03-31, From 2023-01-01 |
| 2022-12-31 | $113.0K | -59.2% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $277.0K | -2.1% | 2024-04-01, From 2021-01-01 |
| 2020-12-31 | $283.0K | -15.3% | 2023-03-13, From 2020-01-01 |
| 2019-12-31 | $334.0K | -41.1% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $567.0K | +62.0% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $350.0K | +177.8% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $126.0K | -47.5% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $240.0K | +757.1% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $28.0K | -86.3% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $204.0K | -68.2% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $642.0K | -48.3% | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | $1.24M | +53.8% | 2014-03-13, From 2011-01-01 |
| 2010-12-31 | $807.0K | +189.2% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $279.0K | n/a | 2012-03-15, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Omeros Corp (OMER) | 2025-12-31 | $65.0K | -60.6% |
| Sionna Therapeutics, Inc. (SION) | 2025-12-31 | $377.0K | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $339.0K | -39.8% |
| Liquidia Corp (LQDA) | 2025-12-31 | $4.34M | -12.4% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $264.0K | -69.6% |
| Rocket Pharmaceuticals, Inc. (RCKT) | 2025-12-31 | $440.0K | -92.5% |
| Amylyx Pharmaceuticals, Inc. (AMLX) | 2025-12-31 | $138.0K | -12.1% |
| Keros Therapeutics, Inc. (KROS) | 2025-12-31 | $1.55M | -19.7% |
| LB Pharmaceuticals Inc (LBRX) | 2025-12-31 | $52.0K | -93.2% |
Compare OMER, SION, SPRY, LQDA side by side · Screen every company in Pharmaceutical Preparations ↗